Patents by Inventor Regis Dupont

Regis Dupont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5023266
    Abstract: Ifenprodil and its analogues are useful for the treatment of psychoses such as schizophrenia.
    Type: Grant
    Filed: January 24, 1990
    Date of Patent: June 11, 1991
    Assignee: Synthelabo
    Inventors: Salomon Z. Langer, Jonathan R. Frost, Johannes Schoemaker, Bernard Gaudilliere, Jean Bertin, Jean Rousseau, Regis Dupont, Alexander E. Wick
  • Patent number: 4950670
    Abstract: A pyrimidinedione derivative which is a compound of formula (I): ##STR1## in which: R1 denotes hydrogen, a halogen, a methyl group or a methoxy group,R2 denotes hydrogen, a C.sub.1 -C.sub.4 alkyl group or a benzyl group,n denotes 2, 3 or 4,X denotes a CH group or nitrogen, andR3 denotes hydrogen, a halogen or a methoxy group when X denotes a CH group, with the proviso that R3 denotes hydrogen when X denotes nitrogen,or a pharmacologically acceptable acid addition salt thereof.
    Type: Grant
    Filed: May 16, 1989
    Date of Patent: August 21, 1990
    Assignee: Synthelabo
    Inventors: Jonathan Frost, Bernard Gaudilliere, Jean Rousseau, Regis Dupont, Philippe Manoury, Daniel Obitz
  • Patent number: 4690931
    Abstract: Compounds of the formula: ##STR1## wherein R.sub.1 is hydrogen, halogen, trifluoromethyl, alkyl, hydroxyl, alkyoxy, benzyloxy, alkanoyloxy, or benzoyloxy, or when R.sub.2 is hydroxyl or methoxy in the 4-position and R.sub.3 is hydrogen, R.sub.1 may also represent hydroxymethyl carbamoyl or alkoxycarbonyl,R.sub.2 is hydrogen, halogen, alkyl, hydroxyl, or alkoxy,R.sub.3 is hydrogen or alkyl,R.sub.4 is alkyl (in which case the compounds are (.+-.)-erythro) or when R.sub.3 represents hydrogen, R.sub.4 may also be hydrogen, and R.sub.5 is hydrogen, halogen, alkyl, alkoxy, or three methoxy groups in the 3-, 4- and 5-positions and pharmaceutically acceptable acid addition salts thereof, with the exclusion of compounds wherein:(a) one of R.sub.1 and R.sub.2 is in the 4-position and is hydroxyl, alkoxy or benzyloxy, the other is in the 3-position and is hydrogen, hydroxyl, alkoxy or benzyloxy, and R.sub.3 and R.sub.5 are hydrogen and wherein:(b) R.sub.1 is in the 4-position and is halogen, R.sub.4 is methyl and R.sub.
    Type: Grant
    Filed: September 9, 1985
    Date of Patent: September 1, 1987
    Assignee: Synthelabo
    Inventors: Alexander Wick, Jonathan Frost, Bernard Gaudilliere, Jean Bertin, Regis Dupont, Jean Rousseau
  • Patent number: 4358451
    Abstract: Pyrimido- and imidazo-pyridoindole derivatives, in the form of racemates or optically active isomers, of formula: ##STR1## in which n=0 or 1, R.sub.1 =H, Hal, alkyl or alkoxy or CF.sub.3, R.sub.2 =H, alkyl, cycloalkyl-alkyl, cycloalkyl, N,N-dialkylaminoalkyl or phenyl, R.sub.3 =H or alkyl and R.sub.4 =H, alkyl or benzyl are useful as anti-anoxia or psychotropic agents in therapy. They are prepared by cyclizing a compound of formula: ##STR2## wherein R.sub.5 is alkyl, by heating it in an acidic medium, such as ethanolic hydrogen chloride.
    Type: Grant
    Filed: January 15, 1980
    Date of Patent: November 9, 1982
    Assignee: Synthelabo
    Inventors: Gabor I. Koletar, Jonathan R. Frost, Regis DuPont, Patrick Lardenois, Claude Morel, Henry Najer
  • Patent number: 4336256
    Abstract: Pyridoindole derivatives of formula ##STR1## n=0 or 1; R.sub.1 =H, Hal, alk, alk--O--, CF.sub.3 ; R.sub.2 =--COOalk; --CONHR.sub.5 (R.sub.5 =H or various substituents); R.sub.3 =H, alk, --COOalk; R.sub.4 =H, Ac, alk, --CONHR.sub.6 (R.sub.6 =H or various substituents), and acid addition salts, except certain known compounds, are useful in treating anoxia and depression and in psychotropic therapy. They are prepared from tryptamine or a derivative thereof by reaction thereof with a pyruvic ester or 3-ethoxycarbonyl-1,2-dioxo-1-ethoxypropane to form compounds in which R.sub.4 is H and R.sub.2 is --COOalk. These compounds are reacted with amines, isocyanates or usual N-acylating or N-alkylating reagents to prepare the other compounds.
    Type: Grant
    Filed: September 4, 1980
    Date of Patent: June 22, 1982
    Assignee: Synthelabo
    Inventors: Gabor I. Koletar, Jonathan B. Frost, Regis DuPont, Patrick Lardenois, Claude Morel, Henry Najer
  • Patent number: 4277476
    Abstract: Derivatives of fluorenes and fluoranthenes, in the form of racemates or of enantiomers, of the formula (I) ##STR1## in which n is 1 or 2, R.sub.1 is a hydrogen or halogen atom or an alkyl or alkoxy radical, R.sub.2 is a hydrogen atom or an alkyl, cycloalkyl, cycloalkylalkyl, benzyl, halogenobenzyl, alkylbenzyl, alkoxybenzyl, acyl, alkoxycarbonyl or alkylaminocarbonyl radical, R.sub.3 is a hydrogen atom or an alkyl radical, R.sub.4 is a hydrogen atom or an alkyl, acyl or aroyl radical, the alkyl and alkoxy radicals or parts of radicals having from 1 to 4 carbon atoms and pharmaceutically acceptable acid addition salts thereof, are therapeutically valuable as anti-anoxia and psychotropic agents.
    Type: Grant
    Filed: July 26, 1979
    Date of Patent: July 7, 1981
    Assignee: Synthelabo
    Inventors: Regis DuPont, Patrick Lardenois, Claude Morel, Jonathan Frost, Gabor I. Koletar
  • Patent number: 4272539
    Abstract: Pyridoindole derivatives of formula ##STR1## n=0 or 1; R.sub.1 =H, Hal, alk, alk-O-, CF.sub.3 ; R.sub.2 =--COOalk; --CONHR.sub.5 (R.sub.5 =H or various substituents); R.sub.3 =H, alk, --COOalk; R.sub.4 =H, Ac, alk, --CONHR.sub.6 (R.sub.6 =H or various substituents), and acid addition salts, except certain known compounds, are useful in treating anoxia and depression and in psychotropic therapy. They are prepared from tryptamine or a derivative thereof by reaction thereof with a pyruvic ester or 3-ethoxycarbonyl-1,2-dioxo-1-ethoxypropane to form compounds in which R.sub.4 is H and R.sub.2 is --COOalk. These compounds are reacted with amines, isocyanates or usual N-acylating or N-alkylating reagents to prepare the other compounds.
    Type: Grant
    Filed: January 15, 1980
    Date of Patent: June 9, 1981
    Assignee: Synthelabo
    Inventors: Gabor I. Koletar, Jonathan R. Frost, Regis Dupont, Patrick Lardenois, Claude Morel, Henry Najer
  • Patent number: 4190657
    Abstract: The present invention relates to new indolo [3,2,1-de]-[1,5]naphthyridine derivatives and their addition salts with pharmaceutically acceptable acids, the preparation of such derivatives and salts and medicaments in which they are present as active principle.
    Type: Grant
    Filed: April 11, 1977
    Date of Patent: February 26, 1980
    Assignee: Synthelabo
    Inventors: Gabor I. Koletar, Henry Najer, Jean P. G. LeFevre, Regis Dupont, Don Pierre R. L. Giudicelli, Claude C. H. Morel
  • Patent number: 4044132
    Abstract: The invention provides a new piperazine derivative, 1-(4-fluoro-3-trifluoromethylthio-phenyl)-piperazine of the formula ##STR1## and its pharmaceutically acceptable acid addition salts, which is useful as a medicament in human and veterinary therapy because of its anorexia-inducing effect.
    Type: Grant
    Filed: March 11, 1976
    Date of Patent: August 23, 1977
    Assignee: Synthelabo
    Inventors: Henry Najer, Regis Dupont, Don Pierre Rene Lucien Giudicelli